Professional Media briefs

The American Academy of Neurology's new medical journal, Neurology: Clinical Practice debuted in December, published by Wolters Kluwer Health's Lippincott Williams & Wilkins (LWW) imprint. The publication will be available in print, online and on the iPad.

Elsevier and the Federation of Biochemical Societies (FEBS) announced launch of FEBS Open Bio, an open-access journal dedicated to publishing articles across the molecular and cellular life sciences.  

Nature Publishing Group (NPG) announced a partnership with Antibodypedia, an online searchable database which links publicly available antibodies with data demonstrating their efficacy and published studies in which they have been used.

The Female Patient named John Hawes to the position of editor. Hawes had been director of strategic communications in the publications division of Pacific Communications.

Wolters Kluwer Health said it acquired Medknow Pvt Ltd, a Mumbai-based publisher of medical, scientific and technical journals. Medknow's stable of 155 journals beefs up Wolters Kluwer's presence in emerging markets.
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.